December 11, 2013 -
M2SYS has announced that it has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition for its RightPatient multi-biometric patient identification system.
Specifically, M2SYS was named as a finalist in the Privacy Security category.
Finalists were selected by a panel of CIOs and other executives from renowned U.S. hospitals and healthcare systems, including Mayo Clinic, Boston Children’s Hospital, Memorial Sloan-Kettering Cancer Center, University of Michigan Hospitals and Health Centers and Beth Israel Deaconess Medical Center.
According to the company, applications were evaluated based on impact on quality of care, patient outcomes, care efficiency, technology innovation, compatibility with IT systems, as well as user-experience, among others.
“It’s exhilarating to be recognized as an innovator in health IT technology as we continue forward on the journey to digitizing healthcare,” Michael Trader, president of M2SYS Technology said. “Our RightPatient multi-biometric patient identification system is already helping many hospitals around the world to increase patient safety, reduce duplicate medical records, eliminate fraud at the point of service, streamline the registration process, and ensure healthcare organizations are sharing clean data across Health Information Exchanges (HIEs) and Integrated Delivery Networks (IDNs). To be singled out as a finalist for the Fierce Health Innovation Awards is an honor and a true testament to the innovative spirit that encapsulates everything we do here at M2SYS.”
Reported previously, The Martin Health System in Stuart, Florida recently deployed the company’s RightPatient iris biometrics patient identification system.
According to a recently published research report, the global healthcare biometrics market is set to reach $5.9 billion by 2019, growing at a CAGR of 25.9%. Growing security concerns with healthcare facilities and medical insurance have so far driven the growth of this market.